EPB108 | Incidence of cardiometabolic outcomes among people living with HIV initiated on INSTI versus non-INSTI antiretroviral therapies | E-poster | Metabolic, lipid and endocrine complications (including lipodystrophy) |
EPB107 | Genome-wide association study of plasma cholesterol and triglycerides among people living with HIV | E-poster | Metabolic, lipid and endocrine complications (including lipodystrophy) |
EPB106 | Non-alcoholic to metabolic associated fatty liver disease: cardiovascular implications of a change in terminology in patients living with HIV | E-poster | Other non-communicable diseases |
EPB105 | Associations between quality of oral health, HIV status, oral health practices and mental health status among adolescents in Nigeria: a cross-sectional study | E-poster | Other non-communicable diseases |
EPB104 | Prevalence and severity of nonalcoholic fatty liver disease in obese and non-obese patients with and without HIV infection in Asia | E-poster | Other non-communicable diseases |
EPB103 | Should HIV control programmes in Africa screen patients with HIV for multi-morbidity: findings from non-communicable diseases screening in the META trial in Dar es Salaam, Tanzania | E-poster | Other non-communicable diseases |
EPB102 | Factors associated with lower physical function among adults with HIV in the United States | E-poster | Other non-communicable diseases |
EPB101 | Increasing non-AIDS comorbidity burden among hospitalized persons with HIV (PWH) in the US and Canada | E-poster | Other non-communicable diseases |
EPB100 | Women with HIV are at higher risk for obstructive lung disease in Kampala, Uganda after pulmonary tuberculosis | E-poster | Other non-communicable diseases |
EPB099 | Epigenome-wide association study of liver function biomarkers identifies albumin-associated DNA methylation sites among male veterans with HIV | E-poster | Other non-communicable diseases |